SY-1365

98%

  • Product Code: 109706
  CAS:    1816989-16-8
Molecular Weight: 586.2572 g./mol Molecular Formula: C₃₁H₃₅ClN₈O₂
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: -20°C, airtight, dry
Product Description: SY-1365 is primarily investigated for its potential in cancer therapy, particularly targeting CDK7, a cyclin-dependent kinase involved in cell cycle regulation and transcription. Its application focuses on disrupting the growth of cancer cells by inhibiting CDK7, which plays a critical role in controlling cell division and gene expression. This makes it a promising candidate for treating various cancers, including ovarian, breast, and hematologic malignancies. Research is ongoing to evaluate its efficacy and safety in clinical trials, with the aim of developing it as a targeted therapy for patients with limited treatment options.
Product Specification:
Test Specification
Appearance Crystal
Purity (%) 97.5-100
Infrared Spectrum Conforms To Structure
NMR Conforms To Structure
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.010 10-20 days $4,166.19
+
-
SY-1365
SY-1365 is primarily investigated for its potential in cancer therapy, particularly targeting CDK7, a cyclin-dependent kinase involved in cell cycle regulation and transcription. Its application focuses on disrupting the growth of cancer cells by inhibiting CDK7, which plays a critical role in controlling cell division and gene expression. This makes it a promising candidate for treating various cancers, including ovarian, breast, and hematologic malignancies. Research is ongoing to evaluate its efficacy and safety in clinical trials, with the aim of developing it as a targeted therapy for patients with limited treatment options.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: $0.00
$0.00 Total :